These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3. Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, Uskokovic MR, Brenner RV, Evans SR. Cancer Res; 1994 Aug 01; 54(15):4057-64. PubMed ID: 8033137 [Abstract] [Full Text] [Related]
6. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP. Anticancer Res; 1999 Aug 01; 19(3A):1689-97. PubMed ID: 10470102 [Abstract] [Full Text] [Related]
10. Growth inhibition of human colon adenocarcinoma-derived Caco-2 cells by 1,25-dihydroxyvitamin D3 and two synthetic analogs: relation to in vitro hypercalcemic potential. Cross HS, Farsoudi KH, Peterlik M. Naunyn Schmiedebergs Arch Pharmacol; 1993 Jan 01; 347(1):105-10. PubMed ID: 8446178 [Abstract] [Full Text] [Related]
17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov 01; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]